Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin.
Saved in:
| Title: | Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin. |
|---|---|
| Authors: | Gorodnova, Tatiana V.1 (AUTHOR), Sokolenko, Anna P.1,2 (AUTHOR), Kotiv, Khristina B.1 (AUTHOR), Sokolova, Tatiana N.1 (AUTHOR), Ivantsov, Alexandr O.1,2 (AUTHOR), Guseynov, Konstantin D.1 (AUTHOR), Nekrasova, Ekaterina A.1 (AUTHOR), Smirnova, Olga A.1 (AUTHOR), Berlev, Igor V.1,3 (AUTHOR), Imyanitov, Evgeny N.1,2,3 (AUTHOR) evgeny@imyanitov.spb.ru |
| Source: | Hereditary Cancer in Clinical Practice. 2/3/2021, Vol. 19 Issue 1, p1-7. 7p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
